IP Accountability In Clinical Research Is Easy But Can Cause Major Issues If Neglected By CRAs

Investigational Product accountability is important for verifying that patients took study drug as directed. Some CRAs overlook IP accountability and instead focus solely on source data verification. Experienced CRAs know that spending as little as 30 minutes on IP accountability can go a long way towards reducing the number of discrepancies and deviations due to patient compliance.